04.21 - CHF Pharm (Ostrom) Flashcards

(85 cards)

1
Q

Tx for Stage A CHF

A

Preventive Measures, ACEi’s and ARB’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

___ is a vasodilator that acts directly on vascular SM

A

Hydralazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 “other” Considerations for Diuretic Tx in CHF

A

ACEi’s and ARB’s also have diuretic effects; Spirinolactone, Eplerenone have benefits beyond diuretic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 BB’s approved for CHF

A

Metoprolol, Carvedilol, Bisoprolol (Carved Bison Meat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 most common AE’s of ACEi’s

A

First dose hypotension, Na depletion, Dry Cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 most common AE’s of Aliskerin

A

First dose hypotension, Hyperkalemia, Angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 most common AE’s of ARB’s

A

First dose hypotension, Hyperkalemia, Hepatic Dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 Drugs that interact with Digoxin

A

Quinidine, Amiodarone, Verapamil, Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ACEi effect on Bradykinin

A

Increase levels due to inhibitor of metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACEi’s end in

A

pril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advantage of ACEi’s

A

Little effect on lipids or sexual function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advantage of Milrinone over Dobutamine

A

Milrinone doesn’t desensitize receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aldosterone and AngII combine to stimulate

A

fibrosis in cardiac tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Angiotensin Receptor Antagonists end in

A

tan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Arterial Vasodilators alone may what change in Frank-Starling Curve

A

Left and Upward

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Arterial Vasodilators work best when combined with

A

Inotrope and Diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

At what stage do you add beta blockers

A

B (NYHA I)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

At what stage do you add Diuretic, Digoxin

A

C (NYHA II, III)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

BB approved for CHF only in Europe

A

Nebivolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

BB least likely to induce increase TPR cause by reflex vasoconstriction

A

Carvedilol: alpha1 antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BB that potentiates NO in vasculature; approved for HTN but not CHF

A

Nevivolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benefit of Nesiritide is comparable to

A

IV nitroglycerin but hypotension may persist longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Can hemodynamic drugs slow progression of CHF?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Diuretics effects on Preload, CO

A

Reduce Preload, Do NOT increase CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Do Diuretics improve survival or prognosis in CHF?
No (except for spironolactone/Eplerenone)
26
Dobutamine and Milrinone can cause
Arrhythmias
27
Does mortality change in CHF with Digoxin
Yes, reduced
28
Drug interactions of Aliskerin
Inhibits P-Glycoprotein (Erythromycin, Amiodarone)
29
Effect on K of Spirinolactone
K-Sparing
30
Hemodynamic effects of Natriuretic Peptides
(1) Reduce vent filling pressure; (2) Inhibit renin, aldosterone release; (3) Inhibit Na reabs; (4) Selective afferent arteriole vasodilation
31
How can Loop Diuretics cause arrhythmias
Hypokalemia
32
How do Arterial Vasodilators Increase CO
Reduce Afterload
33
How do beta blockers affect receptor numbers
Increase (reverse desensitization)
34
How do you favor gene regulation pathway over inotropic pathway
Slower, sustained catecholamine signaling (BAR internalization)
35
How does BP change with Atropine?
Doesn't
36
How does Digoxin affect Pressure-Volume Curve
Shifts upward: CO increases at each level of preload
37
How is Digoxin excreted
Kidneys
38
In which patients is benefit of Digoxin greatest
EF < 0.25, Cardiac Enlargement, NYHA III/IV
39
Increased Aldosterone may worsen
LV function
40
Interactions of Diuretics
NSAIDs reduce efficacy
41
Leading cause of death in Class II, III CHF?
Arrhythmias
42
Long term hemodynamic effects of BB's in CHF
Inc CO, Decreased LVEDP
43
Main ACEi adverse effect
Dry Cough
44
Mitogenic effects of Ang II
Hypertrophy of myocytes and vascular SM; Cardiac and vascular fibrosis, remodeling; Atherosclerosis
45
MOA of Aliskerin
Renin inhibitor
46
MOA of Dobutamine
Beta-1-selective agonist: Intropic effects thru cAMP, PKA
47
MOA of Hydrochlorothiazide
Diuretic
48
MOA of Milrinone
PDE inhibitor: Increase cAMP level
49
MOA of Neseritide (3)
(1) Vaso, Venodilation; (2) Increase GFR, Decrease Na reab; (3) Suppress Renin-Ag and SNS
50
Most commonly used Diuretics
Furosemide (Loop); Spirinolactone (Aldosterone ant)
51
Most powerful diuretic class
Loop
52
Need to combine arterial vasodilator with __ to reduce both preload and afterload
Venodilator (nitrate)
53
Preganancy status of ACEi's
Fetotoxic
54
Primary Vasodilators:
Hydralazine, Nitrates
55
Renin inhibitor
Aliskiren
56
Role of Bradykinin
Vasodilator and antifibrotic mediator (downregulated by ACEi's)
57
Role of Phosphobalmin
Regulates SR pump that removes Ca2
58
Short term hemodynamic effects of BB's in CHF
Dec CO, BP
59
T/F: BB's always decrease function in CHF?
False, actually improve
60
T/F: BB's can't slow progression of CHF
FALSE
61
Tachyphylaxis
Depletion of presynaptic vesicles within matter of minutes
62
Toxicities of Digoxin
AV Block, Atrial/Vent Arrhythmias, Visual Changes (Halos)
63
Toxicities of Diuretics
Electrolyte disturbances, Ototoxicity (Loop)
64
Toxicity of Hydralazine
Nausea, Anorexia, +FANA
65
Tx for Stage B CHF
Preventive, ACEi's, ARB's, Beta Blockers
66
Tx for Stage C CHF
Preventive, ACEi's, ARB's, BB's, Digoxin/ Spironolactone
67
Tx for Stage D CHF
Preventive, ACEi's, ARB's, BB's, Digoxin/ Spironolactone, IV inotropes, Transplant
68
Use of Hydralazine is limited to what patients
Can't tolerate ACEi's
69
Use of Nesiritide should be limited to those who
do not respond to nitroglycerin
70
What attenuates deleterious effects of high levels of NE and Epi?
Beta blockers
71
What does reduced afterload do to pressure-volume curve
Left and Upward
72
What is counterintuitive about BB's in CHF tx?
Slow progression
73
What is Lusitropy
Activation of beta receptors also activates SR pump that removes Ca2+
74
What is needed for rapid onset of Digoxin action
Loading dose
75
What is Nesiritide
Recombinant b-type natriuretic peptide (BNP)
76
What is primary goal of tx in patients with early (A and B) CHF?
Reign in overactivation of neurohormonal mediators, such as catecholamines and Ang 2
77
What limits long-term dobutamine use
Desensitization of receptors; Arrhythmias
78
What prevents vasodilator effect of Dobutamine?
BB therapy (creates unoppose a1 agonist)
79
When is Nesiritide indicated?
IV tx of decompensated class IV (decompensated) CHF
80
Which anti-HTN drugs should never be given to pregnant or nursing women?
ACEi's or ARB's
81
Which does not increase vasodilator Bradykinin
ARB's
82
Which is more effective at reducing CHF endopoints: ARB's or ACEi's?
Equal
83
Which is preferred: ACEi's or ARB's?
ACEi's, unless patient can't tolerate side effects
84
Which shows aldosterone "escape"?: ACEi or ARB
ACEi
85
Who responds less favorably to ACEi's
Aas or Low-renin HTN patients